Skip to content

Efficacy of Lavender Essential Oil Chest Wraps in Infants With Bronchiolitis

Efficacy of Lavender Essential Oil Chest Wraps in Improving Cough and Respiratory Distress in Infants With Bronchiolitis: a Multicenter Randomized Controlled Trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06108648
Enrollment
400
Registered
2023-10-31
Start date
2023-12-07
Completion date
2026-04-30
Last updated
2025-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiolitis

Keywords

bronchiolitis, infant, cough, essential oil, lavendula, complementary therapies

Brief summary

The goal of this clinical trial is to learn if lavender essential oil chest wraps relieve cough in infants with bronchiolitis compared to standard care. Furthermore, the researchers will evaluate if breathing difficulties, nighttime awakening and impact on parents will be improved by the lavender oil chest wraps. Infants will be randomized to receive standard care with the addition of lavender oil chest wraps or to receive standard care alone. The study will take place in two locations in Switzerland, at the Geneva University Hospital and the Fribourg Cantonal Hospital.

Interventions

DRUGLavender essential oil 10%, diluted in 90% olive oil

Lavender chest wrap: Before the first application pour 10-15 ml of lavender essential oil 10% evenly on the cotton cloth. Put the soaked cotton in the plastic bag, close it and put it to heat in two heating pads (2-5 minutes) so that the oil is distributed on all the fabric. Place the cotton cloth around the patient's chest. Cover the cotton cloth with a woolen fabric that is 2 cm larger than the cotton cloth.

OTHERControl

Standard care according to national standards.

Sponsors

University Hospital, Geneva
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Patients are randomized to receive standard care with additional lavender essential oil chest wrap during two nights of hospitalization or standard care alone.

Eligibility

Sex/Gender
ALL
Age
No minimum to 11 Months
Healthy volunteers
No

Inclusion criteria

* Bronchiolitis: clinical diagnosis based on the combination of respiratory distress (tachypnea, grunting, nasal flaring, retractions, and/or need for supplementary oxygen) and fine crackles sometimes accompanied by wheezing on auscultation. * Hospitalization. * Written informed consent.

Exclusion criteria

* Patients with underlying diseases that impact respiratory or heart function (congenital heart disease, congenital malformation of the lung or airway system and severe chronic lung disease). * More than 3 episodes of bronchiolitis. * Critically ill infants who have an immediate need for intensive care unit (ICU) admission. * Respiratory deterioration needing Continuous positive airway pressure (CPAP) or transfer to ICU during study enrollment. * Atopic dermatitis, eczema or other skin lesions (particularly on the chest). * Oncologic disease. * Premature infants with mild bronchopulmonary dysplasia will not be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Cough frequencyUp to 2 daysNumber of coughs per hour measured with Hyfe CoughMonitor (Hyfe Inc)

Secondary

MeasureTime frameDescription
Respiratory rateBaseline, 1 hour, 4 hoursNumber of breaths per minute
Oxygen supplementation requirementImmediately at discharge from hospitalPresence of oxygen supplementation during hospital stay (yes/no)
Oxygen supplementation durationImmediately at discharge from hospitalNumber of hours of oxygen supplementation
Crying episodesUp to 2 daysNumber of crying episodes noted by parents on crying calendar
Hospital length of stayImmediately at discharge from hospitalHospital length of stay in number of days, Geneva site only
Parental satisfaction assessed with patient satisfaction questionnaireImmediately at discharge from hospitalSatisfaction of parents will be measured by a 10-item, four-point Likert scale questionnaire that has a 3-dimensional structure, i.e. overall satisfaction; perceived effectiveness; parental information and involvement. Scale range from 1 (not at all) to 4 (a lot). Higher scores indicate greater satisfaction.
Impact on parents assessed by the Impact of Bronchiolitis Hospitalization Questionnaire (IBHQ)Immediately at discharge from hospitalImpact from the hospitalization on parents will be measured using IBHQ, a 46-item, four-point Likert scale that has a 12-dimensional structure, i.e. worries and distress; fear for future; guilt; impact on daily organization; physical impact; impact on behaviour with hospitalized child; financial impact; disturbed breastfeeding; physical reaction of hospitalized child; impact on feeding of hospitalized child; impact on behaviour with other children; sibling's reaction. Scale ranges from 1 (not at all) to 4 (a lot). Higher scores indicate higher impact on parents.
Maximum oxygen supplementationImmediately at discharge from hospitalMaximum oxygen flow in L/min

Countries

Switzerland

Contacts

Primary ContactFabiola Stollar, MD, PhD
Fabiola.stollar@hcuge.ch+41795534380
Backup ContactTido von Schoen-Angerer, MD, MPH
tido.von.schoenangerer@gmail.com+41766159263

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026